David Martínez-Cuadrón

38PUBLICATIONS
144CO-AUTHORS
OtorhinolaryngologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Apr 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

|Feb 11, 2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard

|Oct 13, 2025
Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Pau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua

|Sep 13, 2025
Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study.

Antonio Solana-Altabella, Irene Navarro-Vicente, Eduardo Rodríguez-Arbolí

|Sep 01, 2025
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry.

Ana Alfonso-Pierola, David Martinez-Cuadrón, Rebeca Rodríguez-Veiga

|Aug 30, 2025
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.

Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull

Pageof 7

Frequent Collaborators

24 joint publications

Pau Montesinos

16 joint publications

MiguelÁngel Sanz

15 joint publications

Antonio Solana-Altabella

13 joint publications

Juan Eduardo Megías-Vericat